Imagine a clinic without walls ... a clinical trial that reaches beyond borders.
Sample collection at home is revolutionizing science and healthcare.
Learn how you can use Mitra® microsamplers to provide individuals
a convenient way to self-collect specimen samples for mailing directly to the lab.
A major challenge of clinical studies is recruiting and retaining participants.
Frequent reasons cited for low recruitment and high dropout rates include:
Study participants and patients find regular clinic visits for tests to be burdensome, leading to poor adherence, compliance, and a negative patient experience.
Remote specimen collection with Mitra® microsamplers eliminates frequent clinic visits for tests, reducing the burden on participants and overcoming the barriers to study participation.
In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications.
To overcome barriers to subject recruitment and retention, many study sponsors provide dried blood spot (DBS) cards to participants for convenient home blood collection. Yet, there are some disadvantages of DBS cards. DBS cards are difficult to use, leading to many low-quality samples that cannot be included in studies. Labs seek alternatives that would still enable study participants to self-collect blood samples at home.
Enter the Mitra® microsampler, which is designed for remote sampling with precision. This easy-to-use device allows participants to self-collect an accurate blood sample at home. The Mitra offers the convenience of home sampling, but overcomes the disadvantages of DBS cards to consistently deliver reliable results.
High sample quality, precise volume (< 4% RSD)
Simply touch the Mitra® device tip to a drop of fluid and watch it absorb in seconds
No need for frequent clinic visits, cold-chain shipping, or freezers for storage
Send Mitra samples through the mail and process them in a high throughput workflow
>140 Mitra manuscripts and a staff of microsampling experts to support you
Volumetric specimen collection enables accurate insights
Mitra devices are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). The Mitra Microsampling Device is not specific to any clinical test nor does it provide a clinical diagnostic outcome of any nature. Clinical diagnostic laboratories, using the Mitra device for specimen collection, must validate tests according to their organizational needs and comply with relevant regulations.
Safer, simpler, smarter, and more convenient.